Xiamen Amoytop Biotech is a Distributor/Import Export, Manufacturer/Innovator, Contract Service, Consumer Goods, CMO/CDMO, Biopharmaceutical company, Contract Research Organisation (CRO) company operating in the pharmaceutical industry.
AMOYTOP BIOTECH, the leading manufacturer of recombinant bio-pharmaceutical products in China with cGMP, produces Molgramostim, Filgrastim, Oprelvekin, and Peginterferon alfa 2b, marketing in China and exporting to many countries, and provides bio-reagents for Lab and R&D, such as Interleukin-4, TNF-alfa, IFN-gamma, IL-15, SCF, etc. AMOYTOP is also developing Y-shaped branch PEG Drug Delivery Technology in: Pegfilgrastim, Pegsomatropin and Peg-EPO. AMOYTOP, the first and largest company to launch domestic Molgramostim in China, is Molgramostim Reference Standard supplier to National Institutes for Food and Drug Control (NIFDC), China. AMOYTOP also provides service as Contract manufacturer and Contract research according to different requirements.
Company type
Distributor/Import Export, Manufacturer/Innovator, Contract Service, Consumer Goods, CMO/CDMO, Biopharmaceutical company, Contract Research Organisation (CRO)
Products and services
Biopharmaceuticals
Markets
Oceania, North America (USA, Canada), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Xiamen Amoytop Biotech, No.330 Wengjiao Road, Xinyang Industry Zone, Xiamen, China, 361028
